StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.10−0.00 (-0.45%)

Close on Nov 18, 2026Market cap $57.73MP/E –Yield –

OKYO Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for OKYO Pharma

OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More OKYO Pharma figures

See a number that looks wrong?